Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 4/20 | 0.57 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | CA12 | O43570 | 3/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | VCP | P55072 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL619500 | 0.96 | EPHX2 (0.62) | EPHX2TSHRCA12CA14NPSR1 | |
| SCHEMBL1202915 | 0.94 | EPHX2 (0.65) | EPHX2TSHRCA12CA14NPSR1 | |
| SCHEMBL12931771 | 0.94 | EPHX2 (0.65) | EPHX2TSHRCA12CA14NPSR1 | |
| SCHEMBL16473262 | 0.94 | EPHX2 (0.65) | EPHX2TSHRCA12CA14NPSR1 | |
| SCHEMBL9805865 | 0.92 | EPHX2 (0.51) | EPHX2TSHRCA12CA14VCP | |
| Hydrochloric Acid SCHEMBL7295649 | 0.90 | EPHX2 (0.50) | EPHX2TSHRCA12CA14VCP | |
| SCHEMBL3649522 | 0.85 | EPHX2 (0.64) | EPHX2TSHRKDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL22927034 | 0.83 | EPHX2 (0.45) | EPHX2TSHRCA12CA14VCP | |
| SCHEMBL11288210 | 0.83 | EPHX2 (0.45) | EPHX2TSHRCA12CA14VCP | |
| SCHEMBL3667582 | 0.83 | SMYD3 (0.44) | EPHX2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110546145-A | Azaaryl derivative, preparation method and pharmaceutical application thereof | ABBISKO THERAPEUTICS CO LTD | 2019-12-06 | — | — | CN | disclosed |
| EP-1021411-B1 | BENZAMIDE DERIVATIVES AS THROMBIN INHIBITORS | GLAXO GROUP LTD (GB) | 2003-03-05 | — | — | EP | disclosed |
| US-6326386-B1 | ANTICOAGULANT | GLAXO GROUP LIMITED (GB) | 2001-12-04 | — | — | US | disclosed |
| EP-1021411-A1 | BENZAMIDE DERIVATIVES AS THROMBIN INHIBITORS | GLAXO GROUP LIMITED (GB) | 2000-07-26 | — | — | EP | disclosed |
| WO-1997022589-A1 | BENZAMIDE DERIVATIVES AS THROMBIN INHIBITORS | GLAXO GROUP LIMITED (GB) | 1997-06-26 | — | — | WO | disclosed |